name: Lymphoma
category: Cancer
parents:
- Hematologic Malignancy
disease_term:
  preferred_term: lymphoma
  term:
    id: MONDO:0005062
    label: lymphoma
description: >-
  Lymphoma is a spectrum of malignant neoplasms of the lymphoid system that can
  involve lymph nodes and extranodal organs.
has_subtypes:
- name: Non-Hodgkin Lymphoma
  description: Broad category of lymphoid malignancies distinct from Hodgkin lymphoma.
  evidence:
  - reference: PMID:31894937
    supports: SUPPORT
    snippet: "It is traditionally classified broadly as non-Hodgkin or Hodgkin lymphoma."
    explanation: The abstract states lymphoma is classified as non-Hodgkin or Hodgkin.
- name: Hodgkin Lymphoma
  description: Lymphoma subtype classified separately from non-Hodgkin lymphoma.
  evidence:
  - reference: PMID:31894937
    supports: SUPPORT
    snippet: "It is traditionally classified broadly as non-Hodgkin or Hodgkin lymphoma."
    explanation: The abstract states lymphoma is classified as non-Hodgkin or Hodgkin.
pathophysiology:
- name: Malignant Lymphoid Proliferation
  description: >-
    Neoplastic transformation and proliferation of lymphoid cells within the
    lymphatic system leads to lymph node and extranodal involvement.
  evidence:
  - reference: PMID:12764636
    supports: PARTIAL
    snippet: "Lymphoma is a spectrum of malignant neoplasms of the lymphoid system."
    explanation: The abstract defines lymphoma as malignant neoplasms of the lymphoid system.
- name: Hodgkin/Reed-Sternberg Cell Origin
  description: >-
    Hodgkin lymphoma is characterized by clonal Hodgkin/Reed-Sternberg cells
    that derive from B cells.
  cell_types:
  - preferred_term: B cell
    term:
      id: CL:0000236
      label: B cell
  evidence:
  - reference: PMID:15618006
    supports: SUPPORT
    snippet: "HRS cells in nearly all cases of HL derive from B cells, and only rarely from T cells."
    explanation: The abstract states that Hodgkin/Reed-Sternberg cells are derived from B cells.
phenotypes:
- name: Lymphadenopathy
  category: Lymphatic
  frequency: COMMON
  phenotype_term:
    preferred_term: Lymphadenopathy
    term:
      id: HP:0002716
      label: Lymphadenopathy
  evidence:
  - reference: PMID:32433447
    supports: PARTIAL
    snippet: "Hodgkin lymphoma classically presents as lymphadenopathy with contiguous spread with or without associated B symptoms including night sweats, weight loss, and fever."
    explanation: Lymphadenopathy is a classic presenting feature of lymphoma.
- name: Fever
  category: Constitutional
  frequency: COMMON
  phenotype_term:
    preferred_term: Fever
    term:
      id: HP:0001945
      label: Fever
  evidence:
  - reference: PMID:32433447
    supports: PARTIAL
    snippet: "Hodgkin lymphoma classically presents as lymphadenopathy with contiguous spread with or without associated B symptoms including night sweats, weight loss, and fever."
    explanation: Fever is listed among B symptoms in lymphoma presentations.
- name: Night Sweats
  category: Constitutional
  frequency: COMMON
  phenotype_term:
    preferred_term: Night sweats
    term:
      id: HP:0030166
      label: Night sweats
  evidence:
  - reference: PMID:32433447
    supports: PARTIAL
    snippet: "Hodgkin lymphoma classically presents as lymphadenopathy with contiguous spread with or without associated B symptoms including night sweats, weight loss, and fever."
    explanation: Night sweats are listed among B symptoms in lymphoma presentations.
- name: Weight Loss
  category: Constitutional
  frequency: COMMON
  phenotype_term:
    preferred_term: Weight loss
    term:
      id: HP:0001824
      label: Weight loss
  evidence:
  - reference: PMID:32433447
    supports: PARTIAL
    snippet: "Hodgkin lymphoma classically presents as lymphadenopathy with contiguous spread with or without associated B symptoms including night sweats, weight loss, and fever."
    explanation: Weight loss is listed among B symptoms in lymphoma presentations.
treatments:
- name: Chemotherapy
  description: Systemic chemotherapy regimens tailored to lymphoma subtype.
  treatment_term:
    preferred_term: chemotherapy
    term:
      id: MAXO:0000647
      label: chemotherapy
  evidence:
  - reference: PMID:31894937
    supports: SUPPORT
    snippet: "Chemotherapy treatment plans differ between the main subtypes of lymphoma. Non-Hodgkin lymphoma is treated with CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) with or without rituximab (R-CHOP), bendamustine, and lenalidomide."
    explanation: The abstract notes chemotherapy regimens as treatment for lymphoma subtypes.
- name: Radiation Therapy
  description: Radiotherapy combined with chemotherapy for selected lymphoma subtypes.
  treatment_term:
    preferred_term: radiation therapy
    term:
      id: MAXO:0000014
      label: radiation therapy
  evidence:
  - reference: PMID:31894937
    supports: SUPPORT
    snippet: "Hodgkin lymphoma is treated with combined chemotherapy with ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine), Stanford V (a chemotherapy regimen consisting of mechlorethamine, doxorubicin, vinblastine, vincristine, bleomycin, etoposide, and prednisone), or BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) with radiotherapy."
    explanation: The abstract states Hodgkin lymphoma treatment includes radiotherapy with chemotherapy.
datasets:
- accession: geo:GSE10846
  title: Prediction of survival in diffuse large B cell lymphoma treated with chemotherapy plus Rituximab
  description: >-
    Gene expression microarray dataset of 414 diffuse large B-cell lymphoma
    cases used for molecular subtype and outcome analyses.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: MICROARRAY
  sample_types:
  - preferred_term: lymph node tissue
    tissue_term:
      preferred_term: lymph node
      term:
        id: UBERON:0000029
        label: lymph node
  sample_count: 414
  conditions:
  - diffuse large B-cell lymphoma
  notes: >-
    Large lymphoma cohort frequently used for subtype and survival studies.
